Comparison of Laser Lithotripsy With and Without Steerable Ureteroscopic Renal Evacuation (SURE)

Sponsor
Calyxo, Inc. (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04519294
Collaborator
(none)
162
8
2
36.5
20.3
0.6

Study Details

Study Description

Brief Summary

The purpose of the study is to compare the effects, good and/or bad, of a treatment for removing kidney stones called the SURE procedure for stone evacuation to the standard treatment using a basket for stone removal.

Condition or Disease Intervention/Treatment Phase
  • Device: SURE
  • Device: Standard Ureteroscopy (Basketing)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
162 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Prospective, Randomized Study to Evaluate the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation(SURE)Using the CVAC™ Aspiration System Compared to Basketing for the Removal of Renal Calculi Following Laser Lithotripsy
Actual Study Start Date :
Jun 16, 2021
Anticipated Primary Completion Date :
Jul 1, 2022
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: SURE

Device: SURE
The SURE stone evacuation procedure is a technique intended to more easily and completely remove a kidney stone during a kidney stone treatment. The urologist first uses a laser to break the kidney stone into small pieces. Then with the SURE procedure, the pieces are gently vacuumed out of the kidney instead of retrieving the pieces one-by-one with a basket or leaving them to pass naturally in the urine. Basketing is allowed and might be used with the SURE procedure, if needed to remove some small stones.

Active Comparator: Standard Ureteroscopy (Basketing)

Device: Standard Ureteroscopy (Basketing)
This is a treatment in which the urologist uses a laser to break a kidney stone into small pieces and then uses a tool called a basket to retrieve the pieces one at a time.

Outcome Measures

Primary Outcome Measures

  1. SFR [30 days]

    Stone Free Rate

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Candidate for ureteroscopy with laser lithotripsy;

  • Presence of renal stone(s);

  • Be willing and able to return for all study-related follow up procedures; and,

  • Have been informed of the nature of the study, agreeing to its requirements, and have signed the IRB approved informed consent.

Exclusion Criteria:
  • BMI > 45;

  • Significant comorbidities;

  • Bladder, ureteral or kidney abnormalities;

  • Pregnant individuals; or

  • Unable to meet the treatment and follow up protocol requirements.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Arizona Institute of Urology Tucson Arizona United States 85704
2 Johns Hopkins Baltimore Maryland United States 21287
3 New Jersey Urology Voorhees New Jersey United States 08043
4 Prisma Health Greenville South Carolina United States 29650
5 Urology Austin Austin Texas United States 78654
6 Dell Medical School, The University of Texas at Austin Austin Texas United States 78712
7 UT Southwestern Medical Center Dallas Texas United States 75390
8 Urology of Virginia Virginia Beach Virginia United States 23462

Sponsors and Collaborators

  • Calyxo, Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Calyxo, Inc.
ClinicalTrials.gov Identifier:
NCT04519294
Other Study ID Numbers:
  • CP00001
First Posted:
Aug 19, 2020
Last Update Posted:
Feb 17, 2022
Last Verified:
Feb 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 17, 2022